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Studies on the role of central catecholaminergic mechanisms 
in the antidotal effect of the oxime H I 6 in soman poisoned mice 
C . Reithmann, Η. Arbogast, Μ. Hallek, G . Auburger, and L . Szinicz 
Institut für Pharmakologie und Toxikologie der Akademie des Sanitäts- und Gesundheitswesens der Bundeswehr - BSW, 
Ingolstädter Landstrasse 100, D-8046 Garching-Hochbrück, Federal Republic of Germany 
Abstract. The effects of atropine and the oxime H I 6 on 
running performance, brain and plasma Cholinesterase ac-
tivity and brain catecholamines were investigated in mice 
intoxicated with sublethal doses of soman (100 μg/kg s.c.). 
The running time on a rotating mash wire drum (total run­
ning time 60 min) after injection of soman was reduced to 
17.2 min. Treatment with atropine (10 mg/kg i.p.) or H I 6 
(55 mg/kg i.p.) improved the running peformance to 48.2 
and 44.8 min, respectively. Cholinesterase activity was de­
creased in soman poisoned mice to 47.3% in plasma and 
43.5% in brain. Therapy with the oxime H I 6 resulted in a 
reactivation of soman-inhibited peripheral Cholinesterase 
to 76.6%, but failed to reactivate central Cholinesterase. 
Dopamine levels in mice brain were elevated in soman 
poisoning by 23.2%, whereas noradrenaline levels re­
mained unchanged. The increase in brain dopamine levels 
was antagonized by atropine as well as by H I 6. The results 
of this study lead to the speculation that central dopamin­
ergic mechanisms may be involved in soman toxicity as 
well as in the antidotal action of atropine and the mainly 
peripherally acting oxime H I 6. 
Key words: Cholinesterase — Soman — Oxime — H I 6 — 
Dopamine 
Introduction 
The combination of atropine, an oxime and diazepam is 
an effective therapy in poisoning with Cholinesterase 
( C h E ) inhibiting organophosphates. However, soman 
(1,2,2-trimethylpropymethylphosphonofluridate), an ex­
tremely potent anticholinesterase agent, is resistant to this 
treatment. Recently, a series of new bispyridinium oximes 
originating from the laboratory of Prof I Hagedorn at 
Freiburg ( F R G ) have been shown in several animal species 
to be very effective against soman poisoning. Among 
them, H I 6 was the least toxic and most effective one (Cle­
ment 1981; Wolthuis et al. 1984; Arbogast 1987). 
The beneficial effects of H I 6 are generally thought to 
be due to the reactivation of soman-inhibited acetylcholin­
esterase ( A C h E ) , but the mechanism of action of the oxime 
is not fully elucidated: Soman exerts its effects predomi­
nately on the central nervous system, whereas H I 6 crosses 
the blood-brain barrier only in small amounts and reacti-
Offprint requests to: L. Szinicz 
vates peripheral but only causes a slight reactivation of 
central acetylcholinesterase. Therefore peripheral reactiva­
tion of soman inhibited acetylcholinesterase (Clement 
1982; Clement and Lockwood 1982), direct anticholinergic 
actions (French et al. 1983) and other noncholinergic cen­
tral mechanisms (Lundy and Shih 1983) have been as­
sumed to explain the mechanism of the protective action 
of H I 6 in soman poisoning. Certain central actions of an­
ticholinesterases seem to be exerted via a release of cate­
cholamines (Varagic and Krstic 1966; Van Meter and 
Karczmar 1971; Glisson et al. 1974). In organophosphate 
intoxication an elevation in dopamine levels and a de­
crease in noradrenaline levels have been shown in various 
brain parts (Glisson et al. 1972, 1974; Coudray-Loucas et 
al. 1982). The purpose of this study was to determine if 
central catecholaminergic mechanisms may be involved in 
the protective effect of H I 6 in organophosphate poi­
soning. Therefore we studied the effects of the antidotes at­
ropine and H I 6, alone or in combination, on motor per­
formance, central and peripheral Cholinesterase activity 
and central catecholamine levels in soman poisoned mice. 
Materials and methods 
White male N M R I mice (Lippische Versuchstierzucht, Ex­
tertal-Bösingfeld, F R G ) , weighing 20-25 g with tap water 
and standard mice chow ad lib (Altromin) were used. So-
man was 92% pure (titrimetrically). H I 6 (pyridinium-
l-(((4-carbamoyl pyridinio)methoxy)methyl)-2-(hydroxyi-
minomethyl)dichloride) was a gift from Dr Clement, Suf-
field, Canada. Atropine sulfate was obtained from Merck, 
Darmstadt, F R G , noradrenaline hydrochloride, dopamine 
hydrochloride and 3,4-dihydroxybenzylamine hydrobro-
mide were obtained from Sigma, Munich, F R G . All other 
chemicals were of analytical purity and were purchased 
from Sigma, Munich or Merck, Darmstadt ( F R G ) . 
The animals were allowed to adapt for 10 days and 
were then trained for 3 consecutive days, once daily, for 
60 min. 
Running performance. To test the effect of atropine and 
H I 6 on running performance of soman poisoned mice a 
rotating (14 rpm) mash wire drum, 20 cm in diameter, was 
used. The mice received soman and the antidotes immedi-
ately before the running period of 60 min. The time until 
the animals fell from the drum and the number of animals 
which performed the full running period of 60 min were 
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registered. Before injection and after the performance ex­
periment a modified neurologic screening program was 
performed, according to the schedule first published by Ir­
win (1968) testing 26 parameters. The dose of soman ad­
ministered (100 μg/kg) was the model specific E D 9 5 corre­
sponding to about 50% of the L D 5 0 (Oldiges and Schoene 
1970). To test the efficacy of the antidotes a model specific 
E D 5 was used for atropine (10 mg/kg) and H I 6 (55 mg/ 
kg), respectively. The animals, attributed at random, re­
ceived soman s.c. and subsequently atropine and/or H I 6 
i .p. by a double blind procedure. Four hours after the in­
jection of soman and antidotes the animals were anesthe­
tized with ether and sacrificed by exsanguination. The 
brains were removed immediately thereafter and pro­
cessed either for the measurements of Cholinesterase activi­
ty or catecholamine levels or microscopical examination. 
Determination of Cholinesterase activity. Plasma Cholines­
terase activity was measured photometrically according to 
Ellman et al. (1961). For measurement of brain Cholines­
terase activity mouse brains (about 400 mg wet weight) 
were homogenized in 1.5 ml ice-cold 0.9% N a C l and Cho­
linesterase activity was measured according to Ellmann et 
al. (1961) as well as titrimetrically according to Nenner 
(1970). 
Measurement of catecholamine levels in mice brain. Brains 
were homogenized in 1.5 ml ice-cold H C 1 0 4 . Following 
centrifugation (4000 g, 15 min, 4° C ) the supernatants were 
purified on Sephadex G 10 columns as described by Wes-
terink (1983). Recoveries were 54.6 ± 1 6 . 4 % for dopamine 
and 44.3 ± 1 5 . 5 % for noradrenaline (mean ± S D , n = 4). 
Catecholamine standards were weekly prepared in 0.1 Μ 
H C 1 0 4 . Dihydroxybenzylamine hydrobromide was used as 
internal standard. A Hewlett Packard (Munich, F R G ) liq­
uid Chromatograph 1084 Β equipped with a cation ex­
change column (Nucleosil 100- 5 SA, 8 χ 4 x 2 0 0 m m ; 
Macherey-Nagel, Düren, F R G ) and a Metrohm (Herisau, 
Switzerland) electrochemical detector (model Ε 656 with 
641 V A detector) equipped with a glassy carbon electrode 
were used. The electrode potential was set at 0.65 V against 
a Ag/AgCl/c(KCl)-reference electrode (range 5 nA). Sam­
ples (100 μΐ) were injected with a variable injector kit 
(Hewlett Packard 79841 A) . The mobile phase consisted of 
an acetate-citrate buffer (5.75 g/1 citric acid, 9.08 g/1 sodi­
um acetate 3 H 2 0 , 1.73 g/1 N a O H and 50 mg/1 E D T A , p H 
5.2) and 10% methanol. The solutions were filtered (0.5 μπι 
Millipore filter; Eschborn, F R G ) and degassed. 
Statistics. The results were checked for significant differ­
ences by one-way Student's /-test on a ρ < 0.05 level. 
Results 
Effects of atropine and HI 6 on running performance 
In animals receiving soman alone all parameters of the be­
havioural screening program were significantly worsened. 
The running performance and number of animals able to 
run the full time period (60 min) subsequent to the injec­
tion of soman proved to be the most sensitive parameters 
for the evaluation of the effects of atropine and H I 6 
(Fig. 1), and therefore other data are not shown in the text. 
Soman (100 μg/kg s.c.) alone diminished the running time 
from 59.4 min to 17.2 min; the number of animals which 
NaCl S S*H6 S*A S*HI6*A 
Fig. 1. Effect of atropine and HI 6 on motor performance of mice 
impaired by soman. The running period of mice immediately after 
treatment with 0.9% NaCl s.c./i.p. (w = 40), soman (lGX^g/kg) 
s.c./0.9% NaCl i.p. (n - 50), soman (l(H^g/kg) s.c./HI 6 
(55 mg/kg) i.p. (n — 30), soman (lGX^g/kg) s.c./atropine 
(10mg/kg) i.p. (n - 30) and soman (100μg/kg) s.c./HI 6 
(55 mg/kg) i.p./atropine (10 mg/kg) i.p. (n = 30) was measured 
on a rotating (14 rpm) mash wire drum (20 cm in diameter). Mean 
running time ± SEM is shown. * significant difference to the so­
man group, ρ <0.05 
PLASMA 
NaQ S S*H6 S*A 
Fig. 2. (a) Cholinesterase activity in mice plasma after the injec­
tion of 0.9% NaCl (n = 3), soman (n - 7), soman + HI 6 (n = 6) 
and soman + atropine (n = 6). Mean ± SEM. (b) Cholinesterase 
activity in mice brain after the injection of 0.9% NaCl (n = 3), 
soman (n = 3), soman + HI 6 (n = 4) and soman + atropine 
(/! = 5). Mean ± SD. * significant difference to the soman group, 
ρ < 0.05 
performed the full running period decreased from 97.5% to 
12%. Atropine (10 mg/kg i.p.) or H I 6 (55 mg/kg i.p.) 
caused a significant prolongation of the running time to 
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48.2 and 44.8 min, respectively and increased the number 
of mice which performed the full running period to 62.7% 
and 72.6%, respectively. Moreover, in the group treated 
with atropine plus H I 6 all animals were able to run the 
full experimental period of 60 min (Fig. 1). 
Effects of atropine and HI 6 on ChE activity 
Effects of atropine and H I 6 on Cholinesterase activity 
were measured in plasma (Fig. 2 a) and homogenates of the 
whole brain (Fig. 2 b) 4 h after the injection of soman and 
the antidotes. After soman alone plasma Cholinesterase ac­
tivity was reduced from 3,188 U / l ( N a C l s.c. group) to 
1507 U / l (47.3%). H I 6 i.p. led to a significant reactivation 
of plasma Cholinesterase activity to 2442 U / l (76.6%) 
(Fig. 2a). 
In brain homogenates Cholinesterase activity of soman 
poisoned animals was decreased from 8.23 U / g (NaCl s.c. 
group) to 3.58 U / g (43.5%). In contrast to the effects of 
H I 6 on Cholinesterase activity in plasma, H I 6 treatment 
did not reactivate soman-inhibited brain Cholinesterase ac­
tivity (2.9 U/g) (Fig. 2 b). Similar results were obtained by 
titrimetric determination of Cholinesterase activities in 
brain homogenates ( N a C l s . c : 10.4 U / g ; Soman s . c : 
3.7 U / g ; Soman s.c. + H I 6 i .p. : 2.9 U/g). In soman poi­
soned mice treated with atropine i.p. a slight decrease in 
Cholinesterase activities relative to the soman group was 
measured in the plasma as well as in the brain homoge­
nates, but the differences were not statistically significant. 
Effects of atropine and HI 6 on catecholamine levels 
in mice brain 
As previously shown in rats in our laboratory (Katzlmeier, 
unpublished work), an increase in brain dopamine level 
( + 23.3%, ρ <0.05) was also found in mice poisoned with 
soman (Fig. 3 b). The increase in the dopamine level in so­
man poisoning was fully antagonized by atropine as well 
as by the combination of atropine plus H I 6. It was shown 
in these experiments for the first time that not only atro­
pine but also H I 6 alone almost completely prevented the 
increase in brain dopamine levels caused by soman 
(Fig. 3 b). In contrast to the results of other authors (Glis­
son et al. 1974; Coudray-Loucas et al. 1983) the brain nor­
adrenaline levels were found not to be significantly differ­
ent from control animals in mice receiving soman without 
further treatment and in mice treated with the antidotal 
compounds (Fig. 3 a). 
Discussion 
The results presented show a decrease in motor perfor­
mance (Fig. 1) accompanied by a central and peripheral 
A C h E inhibition (Fig. 2) and an increase in brain dopa­
mine content (Fig. 3) in mice receiving a non-lethal dose of 
soman. The motor performance improved in mice when 
treated either with atropine or H I 6 or both (Fig. 1). Be­
cause of the drastic improvement in running performance 
due to atropine, the impact of soman on motor perfor­
mance seems to be mediated also by other mechanisms 
than by the impairment of neuromuscular transmission. 
Although atropine is primarily an antimuscarinic drug and 
H I 6 a peripheral reactivator of Cholinesterase, the im­
provement in both cases was accompanied by a normalisa­







t J : I 
NaCl S*HI6 S*A S*HI6+A 
Fig. 3. Dopamine and noradrenaline levels in mice brain after the 
injection of 0.9% N a C l (n = 7), soman (n = 7-8) , soman + HI 6 
(n = 7), soman + atropine (n = 10), and soman + HI 6 + atro­
pine (n = 5). Mean ± S E M . * significant difference to the soman 
group, ρ <0.05 
dopamine content is important for the function and con­
trol of skeletal muscles, one might speculate that the dis­
turbance and the improvement of motor performance is 
mediated by the respective changes in central dopamine 
content. 
An increase in brain (striatum) dopamine content in 
rats treated with soman was shown by Coudray-Loucas et 
al. (1983) together with a decrease in noradrenaline con­
tent in the hypothalamus. Preliminary data from our labo­
ratory also indicate a mainly striatal increase in dopa­
mine content, as soman led to a higher increase in the stri­
atum ( + 50%) compared to total brain homogenate 
( + 23%) (not shown). A similar effect, namely an increase 
in dopamine and decrease in noradrenaline content due to 
diisopropylfluorophosphate ( D F P ) in rabbits, was report­
ed by Glisson et al. (1972, 1974). Effects of anticholinester­
ase on central catecholaminergic systems were also shown 
by Varagic and Krstic (1966), Van Meter and Karczmar 
(1971) and by Anden and Wachtel (1977). These central 
catecholaminergic actions were explained by cholinergic 
interactions with catecholaminergic pathways via the stimu­
lation of muscarinic receptors (Van Meter and Karczmar 
1971; Anden and Wachtel 1977; Morgan and Pfeil 1978). 
Atropine was reported by Glisson et al. (1972, 1974) to 
prevent the dopamine increase in rabbits due to D F P . The 
results presented show that HI 6, a quaternary ammonium 
compound, only very small amounts of which penetrate 
into the brain (Klimmek et al. 1986), also decreases the 
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cerebral dopamine content in soman poisoning (Fig. 3 b). 
In agreement with these results, no reactivation of cerebral 
C h E by H I 6 was found in the experiments presented, al­
though in the serum a marked effect was observed (Fig. 2). 
In contrast to the data presented and those of Klimmek 
and Eyer (1986), Clement (1982) reported some central 
reactivation by H I 6 in rats after low doses of soman but 
using higher doses of H I 6 (125 mg/kg). Antimuscarinic 
(Clement 1981) and ganglionic blocking properties (Lundy 
and Tremblay 1979) were also reported for H I 6. As 
high doses of the oxime are necessary for these effects, 
other central effects than reactivation seem to be even less 
probable. 
Nevertheless, a decrease in the central dopamine level 
in organophosphate poisoning seems to be possible also by 
some peripherally mediated mechanisms as shown by 
Glisson et al. (1972 and 1974). These authors reported that 
the non-centrally acting atropinemethylnitrate was even 
more effective than atropine in decreasing brain (striatum) 
dopamine content increased by D F P . Although a different 
compound with regard to the primary mechanism, H I 6 
acts also primarily on the peripheral cholinergic nervous 
system. These data support the assumption that the soman-
induced increase in central dopamine level can be im­
proved by a peripheral effect of H I 6 (reactivation), which 
is associated with an improvement of motor performance. 
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